426 related articles for article (PubMed ID: 19595398)
1. Drug-eluting stent fracture and acute coronary syndrome.
Chhatriwalla AK; Cam A; Unzek S; Bhatt DL; Raymond RE; Lincoff AM; Whitlow PL; Ellis SG; Tuzcu EM; Kapadia SR
Cardiovasc Revasc Med; 2009; 10(3):166-71. PubMed ID: 19595398
[TBL] [Abstract][Full Text] [Related]
2. Incidence of thrombosis after implantation of drug-eluting stents in patients with coronary artery disease.
Chen JL; Yang YJ; Gao LJ; Huang JH; Qin XW; Qiao SB; Xu B; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Li JJ; Gao RL
Chin Med J (Engl); 2008 Nov; 121(21):2144-7. PubMed ID: 19080174
[TBL] [Abstract][Full Text] [Related]
3. The incidence and clinical predictors of early stent thrombosis in patients with acute coronary syndrome.
Beinart R; Abu Sham'a R; Segev A; Hod H; Guetta V; Shechter M; Boyko V; Behar S; Matetzky S
Am Heart J; 2010 Jan; 159(1):118-24. PubMed ID: 20102877
[TBL] [Abstract][Full Text] [Related]
4. Drug-eluting coronary stents: many meta-analyses, little benefit.
Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
[TBL] [Abstract][Full Text] [Related]
5. Clinical presentation of patients with in-stent restenosis in the drug-eluting stent era.
Lee MS; Pessegueiro A; Zimmer R; Jurewitz D; Tobis J
J Invasive Cardiol; 2008 Aug; 20(8):401-3. PubMed ID: 18688064
[TBL] [Abstract][Full Text] [Related]
6. Drug-eluting stent thrombosis.
Stähli BE; Camici GG; Tanner FC
Ther Adv Cardiovasc Dis; 2009 Feb; 3(1):45-52. PubMed ID: 19124388
[TBL] [Abstract][Full Text] [Related]
7. The use of drug-eluting stents in venous coronary artery bypass grafts.
Hernandez-Antolín R; Alfonso F; Jimenez P
EuroIntervention; 2009 May; 5 Suppl D():D51-7. PubMed ID: 19736072
[TBL] [Abstract][Full Text] [Related]
8. In-hospital complications and long-term outcomes of the paclitaxel drug-eluting stent in acute ST-elevation myocardial infarction: a real-world experience from a high-volume medical center.
Shammas NW; Shammas GA; Hahn A; Jerin M; Dippel EJ; Winter M
Cardiovasc Revasc Med; 2009; 10(3):151-5. PubMed ID: 19595395
[TBL] [Abstract][Full Text] [Related]
9. Bare metal stent restenosis is not a benign clinical entity.
Chen MS; John JM; Chew DP; Lee DS; Ellis SG; Bhatt DL
Am Heart J; 2006 Jun; 151(6):1260-4. PubMed ID: 16781233
[TBL] [Abstract][Full Text] [Related]
10. Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project.
Nebeker JR; Virmani R; Bennett CL; Hoffman JM; Samore MH; Alvarez J; Davidson CJ; McKoy JM; Raisch DW; Whisenant BK; Yarnold PR; Belknap SM; West DP; Gage JE; Morse RE; Gligoric G; Davidson L; Feldman MD
J Am Coll Cardiol; 2006 Jan; 47(1):175-81. PubMed ID: 16386683
[TBL] [Abstract][Full Text] [Related]
11. Drug-eluting stents: a comprehensive appraisal.
Butt M; Connolly D; Lip GY
Future Cardiol; 2009 Mar; 5(2):141-57. PubMed ID: 19371189
[TBL] [Abstract][Full Text] [Related]
12. 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents.
Caixeta A; Leon MB; Lansky AJ; Nikolsky E; Aoki J; Moses JW; Schofer J; Morice MC; Schampaert E; Kirtane AJ; Popma JJ; Parise H; Fahy M; Mehran R
J Am Coll Cardiol; 2009 Sep; 54(10):894-902. PubMed ID: 19712798
[TBL] [Abstract][Full Text] [Related]
13. Stent thrombosis up to 3 years after stenting for ST-segment elevation myocardial infarction versus for stable angina--comparison of the effects of drug-eluting versus bare-metal stents.
Leibundgut G; Nietlispach F; Pittl U; Brunner-La Rocca H; Kaiser CA; Pfisterer ME
Am Heart J; 2009 Aug; 158(2):271-6. PubMed ID: 19619705
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous coronary intervention in perspective: drug-eluting stents as a model for regulatory review.
Kandzari DE; Farb A; Boam AB
Circ Cardiovasc Interv; 2009 Dec; 2(6):574-9. PubMed ID: 20031776
[No Abstract] [Full Text] [Related]
15. Two-stent technique: a dead duck or alive and kicking?
Belardi JA
Catheter Cardiovasc Interv; 2009 Aug; 74(2):321-2. PubMed ID: 19642180
[No Abstract] [Full Text] [Related]
16. Overview of the 2006 Food and Drug Administration Circulatory System Devices Panel meeting on drug-eluting stent thrombosis.
Pinto Slottow TL; Waksman R
Catheter Cardiovasc Interv; 2007 Jun; 69(7):1064-74. PubMed ID: 17525967
[TBL] [Abstract][Full Text] [Related]
17. Incidence and predictors of drug-eluting stent fracture in human coronary artery a pathologic analysis.
Nakazawa G; Finn AV; Vorpahl M; Ladich E; Kutys R; Balazs I; Kolodgie FD; Virmani R
J Am Coll Cardiol; 2009 Nov; 54(21):1924-31. PubMed ID: 19909872
[TBL] [Abstract][Full Text] [Related]
18. Coronary stent fracture: a cause of cardiac chest pain?
Adlakha S; Sheikh M; Bruhl S; Eltahawy E; Pandya U; Colyer W; Cooper C
Int J Cardiol; 2010 May; 141(2):e23-5. PubMed ID: 19150143
[TBL] [Abstract][Full Text] [Related]
19. Drug-eluting stent thrombosis: the Kounis hypersensitivity-associated acute coronary syndrome revisited.
Chen JP; Hou D; Pendyala L; Goudevenos JA; Kounis NG
JACC Cardiovasc Interv; 2009 Jul; 2(7):583-93. PubMed ID: 19628178
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes after sirolimus-eluting, paclitaxel-eluting, and bare metal stents (from the first phase of the prospective multicenter German DES.DE Registry).
Nienaber CA; Akin I; Schneider S; Senges J; Fetsch T; Tebbe U; Willich SN; Stumpf J; Sabin GV; Silber S; Richardt G; Kuck KH;
Am J Cardiol; 2009 Nov; 104(10):1362-9. PubMed ID: 19892051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
